Original Article

You have full text access to this OnlineOpen article

Racial treatment trends in localized/regional prostate carcinoma: 1992–1999

  1. Willie Underwood III M.D., M.S., M.P.H.1,2,†,*,
  2. James Jackson Ph.D.3,4,
  3. John T. Wei M.D., M.S.1,
  4. Rodney Dunn M.S.1,
  5. Edmond Baker M.D.5,
  6. Sonya DeMonner M.P.H.6,
  7. David P. Wood M.D.1

Article first published online: 20 DEC 2004

DOI: 10.1002/cncr.20796

Issue

Cancer

Cancer

Volume 103, Issue 3, pages 538–545, 1 February 2005

Additional Information

How to Cite

Underwood, W., Jackson, J., Wei, J. T., Dunn, R., Baker, E., DeMonner, S. and Wood, D. P. (2005), Racial treatment trends in localized/regional prostate carcinoma: 1992–1999. Cancer, 103: 538–545. doi: 10.1002/cncr.20796

Author Information

  1. 1

    Division of Clinical Research and Quality Assurance, Department of Urology, University of Michigan, Ann Arbor, Michigan

  2. 2

    Veterans Administration Center for Practice Management and Outcomes Research, Ann Arbor, Michigan

  3. 3

    Research Center for Group Dynamics, Institute for Social Research, University of Michigan, Ann Arbor, Michigan

  4. 4

    Center for African American and African Studies, University of Michigan, Ann Arbor, Michigan

  5. 5

    Department of Surgery, University of Michigan, Ann Arbor, Michigan

  6. 6

    Robert Wood Johnson Clinical Scholars Program, University of Michigan, Ann Arbor, Michigan

  1. †

    Fax: (734) 647-3301

*Department of Urology, University of Michigan, 1500 East Medical Center Drive, Ann Arbor, MI 48109-0330

Publication History

  1. Issue published online: 20 JAN 2005
  2. Article first published online: 20 DEC 2004
  3. Manuscript Accepted: 6 OCT 2004
  4. Manuscript Revised: 7 SEP 2004
  5. Manuscript Received: 3 JUN 2004

Funded by

  • United States Public Health Service (National Cancer Institute). Grant Number: P50CA69568

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (210K)

REFERENCES

  • 1
    Jemal A, Murray T, Samuals A, Ghafoor A, Ward E, Thun M. Cancer statistics, 2003. CA Cancer J Clin. 2003; 53: 5–26.
    Direct Link:
  • 2
    Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1999. CA Cancer J Clin. 1999; 49: 8–31.
    Direct Link:
  • 3
    Schapira MM, McAuliffe TL, Nattinger AB. Treatment of localized prostate cancer in African-American compared with Caucasian men. Less use of aggressive therapy for comparable disease. Medical Care. 1995; 33: 1079–1088.
  • 4
    Mettlin CJ, Murphy GP, McGinnis LS, Menck HR. The National Cancer Data Base report on prostate cancer. American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer. 1995; 76: 1104–1112.
    Direct Link:
  • 5
    Mettlin CJ, Murphy GP, Cunningham MP, Menck HR. The National Cancer Data Base report on race, age, and region variations in prostate cancer treatment. Cancer. 1997; 80: 1261–1266.
    Direct Link:
  • 6
    Harlan L, Brawley O, Pommerenke F, Wali P, Kramer B. Geographic, age, and racial variation in the treatment of local/regional carcinoma of the prostate. J Clin Oncol. 1995; 13: 93–100.
  • 7
    Mettlin CJ, Murphy GP, McDonald CJ, Menck HR. The National Cancer Data Base Report on increased use of brachytherapy for the treatment of patients with prostate carcinoma in the U.S. Cancer. 1999; 86: 1877–1882.
    Direct Link:
  • 8
    Powell I, Gelfand D, Parzuchowski M, Heilbrun L, Franklin A. A successful recruitment process of African American men for early detection of prostate cancer. Cancer. 1995; 75( Suppl): 1880–1884.
    Direct Link:
  • 9
    Gilliland FD, Becker TM, Key CR, Samet JM. Contrasting trends of prostate cancer incidence and mortality in New Mexico's Hispanics, non-Hispanic whites, American Indians, and blacks. Cancer. 1994; 73: 2192–2199.
    Direct Link:
  • 10
    Canto MT, Chu KC. Annual cancer incidence rates for Hispanics in the United States: Surveillance, Epidemiology, and End Results, 1992–1996. Cancer. 2000; 88: 2642–2652.
    Direct Link:
  • 11
    Gilliland FD, Welsh DJ, Hoffman RM, Key CR. Rapid rise and subsequent decline in prostate cancer incidence rates for New Mexico, 1989–1993. Cancer Epidemiol Biomarkers Prev. 1995; 4: 797–800.
  • 12
    SEER. SEER Program code manual, 3rd ed. Bethesda: National Cancer Institute, 1998.
  • 13
    Hankey BF, Ries LA, Edwards BK. The Surveillance, Epidemiology, and End Results Program: a national resource. Cancer Epidemiol Biomarkers Prev. 1999; 8: 1117–1121.
  • 14
    Frey C, McMillen M, Cowen C, Horn J, Kessler L. Representativeness of the Surveillance, Epidemiology, and End Result Program data: recent trends in cancer mortality rates. J Natl Cancer Inst. 1992; 872–877.
  • 15
    Harlan LC, Potosky A, Gilliland FD, et al. Factors associated with initial therapy for clinically localized prostate cancer: Prostate Cancer Outcomes Study. J Natl Cancer Inst. 2001; 93: 1864–1871.
  • 16
    McBean AM, Gornick M. Differences by race in the rates of procedures performed in hospitals for Medicare beneficiaries. Health Care Financing Rev. 1994; 15: 77–90.
  • 17
    Hannan E, van Ryn M, Burke J, et al. Access to coronary artery bypass surgery by race/ethnic and gender among patients who appropriate for surgery. Medical Care. 1999; 37: 68–77.
  • 18
    Harris DR, Andrews R, Elixhauser A. Racial and gender differences in use of procedures for black and white hospitalized adults. Ethn Dis. 1997; 7: 9–105.
  • 19
    Morris CR, Snipes KP, Schlag R, Wright WE. Sociodemographic factors associated with prostatectomy utilization and concordance with the physician data query for prostate cancer (United States). Cancer Causes Control. 1999; 10: 503–511.
  • 20
    Klabunde CN, Potosky AL, Harlan LC, Kramer BS. Trends and black/white differences in treatment for nonmetastatic prostate cancer. Medical Care. 1998; 36: 1337–1348.
  • 21
    Greenwald HP, Henke CJ. HMO membership, treatment, and mortality risk among prostatic cancer patients. Am J Public Health. 1992; 82: 1099–1104.
  • 22
    Potosky AL, Harlan LC, Stanford JL, et al. Prostate cancer practice patterns and quality of life: the Prostate Cancer Outcomes Study. J Natl Cancer Inst. 1999; 91: 1719–1724.
  • 23
    Mazur DJ, Merz JF. Older patients' willingness to trade off urologic adverse outcomes for a better chance at five-year survival in the clinical setting of prostate cancer. J Am Geriatr Soc. 1995; 43: 979–984.
  • 24
    Lubeck DP, Grossfeld GD, Carroll PR. A review of measurement of patient preferences for treatment outcomes after prostate cancer. Urology. 2002; 60: 72–77; discussion, 77–78.
  • 25
    Corbie-Smith G, Thomas SB, St Georg DM. Distrust, race, and research. Arch Intern Med. 2002; 162: 2458–2463.
  • 26
    Leak B, Wei JT, Gabel M, et al. Relevant patient and tumor considerations for early prostate cancer treatment. Semin Urol Oncol. 2002; 20: 39–44.
  • 27
    O'Rourke ME. Decision making and prostate cancer treatment selection: a review. [Review; 50 references.] Semin Oncol Nurs. 2001; 17: 108–117.
  • 28
    Feldman-Stewart D, Brundage MD, Hayter C, et al. What prostate cancer patients should know: variation in professionals' opinions. Radiother Oncol. 1998; 49: 111–123.
  • 29
    Fowler FJ Jr., McNaughton Collins M, Albertsen PC, Zietman A, Elliott DB, Barry MJ. Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer. JAMA. 2000; 283: 3217–3222.
  • 30
    Deber RB, Kraetschmer N, Irvine J. What role do patients wish to play in treatment decision making? Arch Intern Med. 1996; 156: 1414–1420.
  • 31
    Fiscella K, Franks P, Gold MR, Clancy CM. Inequality in quality: addressing socioeconomic, racial, and ethnic disparities in health care. JAMA. 2000; 283: 2579–2584.
  • 32
    Steginga SK, Occhipinti S, Gardiner RA, Yaxley J, Heathcote P. Making decisions about treatment for localized prostate cancer. BJU Int. 2002; 89: 255–260.
    Direct Link:
  • 33
    O'Rourke ME, Germino BB. Prostate cancer treatment decisions: a focus group exploration. Oncol Nurs Forum. 1998; 25: 97–104.
  • 34
    Smedley B, Stith A, Nelson A. Unequal treatment: confronting racial and ethnic disparities in health care. Washington, DC: The National Academies Press, 2002.
  • 35
    Shi L. Experience of primary care by racial and ethnic groups in the United States. Medical Care. 1999; 37: 1068–1077.
  • 36
    D'Amico AV, Whittington R, Malkowicz SB, et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA. 1998; 280: 969–974.
View Full Article (HTML) Get PDF (210K)